Filtruoti pagal Last updated date SelectPoIkiFrom - To Data Pabaigos data This week Šį mėnesį Last week Praeitą mėnesį Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Rezultatai (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency public statement on the suspension of the marketing authorisation for bextra (valdecoxib) in the European Union 27 Spalis 2005NewsMedicines Committee for Orphan Medicinal Products: October 2005 meeting 25 Spalis 2005Press releaseHumanRare diseases EMEA Public Statement on review of recombinant Factor VIII (FVIII) products (Advate, Kogenate Bayer/Helixate NexGen, Kogenate/Helixate, Recombinate, ReFacto) and inhibitor development 18 Spalis 2005News European Medicines Agency update on non-selective NSAIDs 17 Spalis 2005Press releaseMedicines European Medicines Agency: Committee for Medicinal Products for Human Use 10-13 October 2005 13 Spalis 2005Press releaseHumanMedicines European Medicines Agency welcomes new members and observers to its Management Board 30 Rugsėjis 2005Press releaseCorporate Thomas Lönngren reappointed as Executive Director of the European Medicines Agency 28 Rugsėjis 2005Press releaseMedicines European Medicines Agency proposes new, faster scientific advice procedure 22 Rugsėjis 2005Press releaseMedicines European Medicines Agency statement on Herceptin 22 Rugsėjis 2005Press releaseHumanMedicines European Medicines Agency recommends suspension of Hexavac 20 Rugsėjis 2005Press releaseHumanMedicines 1 … 332 333 334 335 336 Page 336 of 380 337 338 339 340 … 380
European Medicines Agency public statement on the suspension of the marketing authorisation for bextra (valdecoxib) in the European Union 27 Spalis 2005NewsMedicines
Committee for Orphan Medicinal Products: October 2005 meeting 25 Spalis 2005Press releaseHumanRare diseases
EMEA Public Statement on review of recombinant Factor VIII (FVIII) products (Advate, Kogenate Bayer/Helixate NexGen, Kogenate/Helixate, Recombinate, ReFacto) and inhibitor development 18 Spalis 2005News
European Medicines Agency: Committee for Medicinal Products for Human Use 10-13 October 2005 13 Spalis 2005Press releaseHumanMedicines
European Medicines Agency welcomes new members and observers to its Management Board 30 Rugsėjis 2005Press releaseCorporate
Thomas Lönngren reappointed as Executive Director of the European Medicines Agency 28 Rugsėjis 2005Press releaseMedicines
European Medicines Agency proposes new, faster scientific advice procedure 22 Rugsėjis 2005Press releaseMedicines
European Medicines Agency recommends suspension of Hexavac 20 Rugsėjis 2005Press releaseHumanMedicines